Background
Methods
SPHERE questionnaires in the Brisbane longitudinal twin study
Selection of unrelated individuals for IRT analysis
Wave |
N
| Mean age | SD | Age range | % Females |
---|---|---|---|---|---|
TW1 | 1695 | 12.64 | 1.33 | 9–18 | 51% |
TW1 pruned for relatedness | 651 | 12.63 | 1.34 | 10–19 | 51% |
TW2 | 1265 | 14.03 | 0.68 | 9–18 | 50% |
TW2 pruned | 602 | 14.02 | 0.68 | 10–18 | 50% |
TM | 1513 | 16.49 | 0.84 | 15–22 | 54% |
TM pruned | 683 | 16.48 | 0.83 | 16–22 | 53% |
TA | 1213 | 18.06 | 3.07 | 11–28 | 56% |
TA pruned | 592 | 18.27 | 3.13 | 12–26 | 56% |
TA + TM pruned –one assessment wave/ individual | 1117 | 55% | |||
TA subset | 543 | 18.67 | 3.02 | 12–26 | 56% |
TM subset | 574 | 16.42 | 0.78 | 16–22 | 54% |
TA + TW2 pruned | 1012 | 52% | |||
TA subset | 506 | 18.93 | 2.98 | 12–26 | 56% |
TW2 subset | 506 | 14.10 | 0.52 | 10–16 | 47% |
TA + TW1 pruned | 1149 | 53% | |||
TA subset | 585 | 18.39 | 3.12 | 12–26 | 55% |
TW1 subset | 564 | 12.50 | 1.15 | 10–19 | 50% |
Protocol of non-parametric IRT analysis
Non-parametric IRT models and concepts
New scores description, three months test-retest, internal consistency and Mokken scale analysis
Composition of the twin sample for heritability, genetic and environmental correlations
Age Bins: | 8 to 12 years | 13 to 14 years | 15 to 16 years | 17 to 28 years | ||
---|---|---|---|---|---|---|
Total number of observations | 1492 | 1552 | 1683 | 959 | ||
Number of repeated observations excluded (same participant with two questionnaires in age bin) | 53 | 154 | 108 | 25 | ||
Number of observations from identical triplet or extra siblings (excluded) | 57 | 27 | 67 | 47 | ||
Final sample size (individuals) for genetic analyses | 1382 | 1371 | 1508 | 887 | ||
Incl. | N complete twin pairs | 634 | 603 | 670 | 242 | |
Incl. | N MZ pairs | 226 | 209 | 230 | 96 | |
N DZ pairs | 408 | 394 | 440 | 146 | ||
N extra sibling | 84 | 114 | 89 | 62 | ||
N twin-sibling pair | 1 | 1 | 0 | 23 | ||
N singletons | 28 | 49 | 79 | 295 | ||
Incl. | N twins | 8 | 8 | 15 | 96 | |
N siblings | 20 | 41 | 64 | 199 | ||
Mean age (SD) [range] | ||||||
% Females | 50% | 50% | 54% | 58% |
8 to 12 years | 13 to 14 years | 15 to 16 years | 17 to 28 years | ||
---|---|---|---|---|---|
N stratified by age at SPHERE-34 assessment | 709 | 907 | 1055 | 739 | |
Demographics | |||||
Mean age at CIDI (SD) | 21.9 (1.7) | 22.9 (2.4) | 23.2 (2.5) | 28.9 (3.1) | |
N (%) Females | 415 (59%) | 522 (58%) | 641 (61%) | 453 (61%) | |
Prevalence | |||||
MDD |
N (%) | 118 (16.6%) | 150 (16.5%) | 172 (16.3%) | 119 (16.1%) |
Mean age onset (SD) | 17.6 (3.1) | 18.2 (3.5) | 18.9 (3.4) | 22.7 (5.3) | |
Social anxiety |
N (%) | 133 (18.7%) | 157 (17.3%) | 182 (17.3%) | 115 (15.5%) |
Mean age onset (SD) | 12.2 (4.5) | 12.4 (4.7) | 11.9 (5.0) | 12.2 (5.5) | |
Alcohol dependence |
N (%) | 169 (23.8%) | 249 (27.4%) | 300 (28.4%) | 188 (25.4%) |
Marijuana dependence |
N (%) | 37 (5.2%) | 59 (6.5%) | 55 (5.2%) | 30 (4.1%) |
Panic disorder |
N (%) (with agoraphobia) | 4 (0.6%) | 7 (0.8%) | 10 (0.9%) | 3 (0.4%) |
Mean age onset (SD) | 17.0 (2.7) | 16.6 (2.9) | 16.4 (3.8) | 22.0 (3.6) | |
N (%) (without agoraphobia) | 13 (1.8%) | 13 (1.4%) | 12 (1.1%) | 15 (2.1%) | |
Mean age onset (SD) | 14.9 (3.6) | 15.1 (4.1) | 16.6 (4.8) | 20.8 (3.8) |
Heritability, genetic and environmental correlation between the scores
Collection of the DSM-IV clinical assessment
Association of new SPHERE scores with DSM-IV diagnoses
Results and discussion
Redefinition of the SPHERE scales in the sample of young adults (TA study)
Anxiety-depression scale
Chronic fatigue scale
Differential item functioning across sex and study wave
Anxiety-depression scale
Chronic fatigue scale
Summary of NIRT analysis: The SPHERE-21 questionnaire
SPHERE-21 mean scores, reliability, internal consistency and Mokken scale analysis
Mean (SD) | Mean Females (SD) | Mean Males (SD) | Sex difference p-value | ||
---|---|---|---|---|---|
TA | |||||
Anxiety-depression | IRT score | −0.39 (1.6) | −0.27 (1.6) | −0.56 (1.7) |
7.6E-4
|
Sum score | 4.6 (4.8) | 5.0 (4.9) | 4.2 (4.6) |
8.8E-4
| |
Chronic fatigue | IRT score | −0.24 (1.5) | −0.19 (1.4) | −0.30 (1.5) | 0.087 |
Sum score | 3.9 (3.4) | 3.9 (3.4) | 3.8 (3.5) | 0.37 | |
TM | |||||
Anxiety-depression | IRT score | −0.44 (1.7) | −0.25 (1.7) | −0.67 (1.6) |
2.5E-6
|
Sum score | 4.1 (4.5) | 4.7 (5.0) | 3.3 (3.7) |
9.3E-10
| |
Chronic fatigue | IRT score | −0.22 (1.5) | −0.15 (1.5) | −0.31 (1.4) | 0.042 |
Sum score | 4.0 (3.4) | 4.2 (3.6) | 3.7 (3.2) | 0.018 | |
TW2 | |||||
Anxiety-depression | IRT score | −0.47 (1.7) | −0.47 (1.7) | −0.46 (1.7) | 0.88 |
Sum score | 3.7 (4.3) | 3.7 (4.2) | 3.7 (4.4) | 0.96 | |
Chronic fatigue | IRT score | −0.28 (1.5) | −0.38 (1.5) | −0.18 (1.5) | 0.031 |
Sum score | 3.6 (3.3) | 3.4 (3.3) | 3.8 (3.3) | 0.079 | |
TW1 | |||||
Anxiety-depression | IRT score | −0.4 (1.6) | −0.48 (1.7) | −0.30 (1.6) | 0.026 |
Sum score | 4.1 (4.4) | 3.9 (4.3) | 4.4 (4.5) | 0.023 | |
Chronic fatigue | IRT score | −0.33 (1.6) | −0.48 (1.6) | −0.18 (1.5) |
2.5E-6
|
Sum score | 3.5 (3.3) | 3.3 (3.3) | 3.8 (3.4) |
9.7E-5
|
TW1 | TW2 | TM | TA | ||
---|---|---|---|---|---|
Anxiety-depression | alpha | 0.88 | 0.87 | 0.87 | 0.86 |
# Hij < 0 | 0 | 0 | 0 | 0 | |
Min(Hi) | 0.29 | 0.24 | 0.28 | 0.24 | |
Items Hi < 0.3 | 3 | 3, 28 | 28 | 3 | |
Chronic fatigue | alpha | 0.79 | 0.79 | 0.78 | 0.79 |
# Hij < 0 | 0 | 0 | 0 | 0 | |
Min(Hi) | 0.24 | 0.26 | 0.25 | 0.23 | |
Items with Hi < 0.3 | 3, 15 | 3, 15, 31 | 3, 15 | 3, 15, 32 |
Heritability, genetic and environmental correlations between the SPHERE-21 scores
Parameter Estimates | Twin pair correlations | |||
---|---|---|---|---|
A | E | rMZ | rDZ | |
Anxiety depression | ||||
8–12 years |
0.41 [0.32,0.49]
|
0.59 [0.51,0.68]
| 0.43 | 0.22 |
13–14 years | 0.42 [0.33,0.5] | 0.58 [0.5,0.67] | 0.38 | 0.32 |
15–16 years | 0.29 [0.2,0.38] | 0.71 [0.62,0.8] | 0.28 | 0.20 |
17–28 years |
0.37 [0.21,0.51]
|
0.63 [0.49,0.79]
| 0.39 | 0.18 |
Chronic fatigue | ||||
8–12 years |
0.42 [0.33,0.51]
|
0.58 [0.49,0.67]
| 0.42 | 0.25 |
13–14 years |
0.51 [0.43,0.59]
|
0.49 [0.41,0.57]
| 0.53 | 0.29 |
15–16 years |
0.35 [0.25,0.44]
|
0.65 [0.56,0.75]
| 0.38 | 0.15 |
17–28 years |
0.27 [0.11,0.41]
|
0.73 [0.59,0.89]
| 0.27 | 0.07 |
SPHERE-21 association with some DSM-IV psychiatric diagnoses
Comparison of SPHERE-21 and Beck’s depression inventory
SPHERE-21 | BDI | |
---|---|---|
Number of items | 14 (for anxiety-depression) | 21 |
Short form for clinical use | SPHERE-12 (six items for anxiety-depression) | BDI-11 |
IRT requirements | Monotonicity verified Good correlation of items with the latent trait | Monotonicity breached for items 9 and 10 Poor correlation of item 19 with the latent trait [53] |
Sex DIF | Limited (DIF < 0.25) | Large DIF for item 14 (DIF = 0.32) Limited otherwise (DIF < 0.25) [53] |
Age group DIF | Limited (DIF < 0.25); comparable construct from age 9 to 28 years | Not tested at item level (IRT) Not investigated in a population sample Comparable structure and internal consistency (Cronbach’s alpha) for adolescent inpatients [98] |
Language(s) | Arabic, Cantonese, Croatian, Dutch, English, Greek, Italian, Japanese, Mandarin, Portuguese, Serbian, Spanish, Turkish, Vietnamesea
| Arabic, Chinese, English, Farsi, Finnish, French, German, Japanese, Korean, Norwegian, Portuguese, Spanish, Swedish, Turkish |
Test-retest | 0.47 [0.23,0.66] at three months | 0.48–0.86 [80] depending on the sample and test-retest interval |
Cronbach’s alpha | 0.87 | |
Heritability | 0.41 [0.32,0.49] between ages nine and 12 years, 0.42 [0.33,0.50] at 13 to 14 years, 0.29 [0.20,0.38] at 15 to 16 years and 0.37 [0.21,0.51] between ages 17 and 28 years (AE models, anxiety-depression scores) | 0.18 [0.05,0.31] (AE model, mean age 31 years, range 16–71) [84] |
Association with DSM-IV diagnoses | Significant from age 15 years with alcohol and Marijuana dependence; and from age 13 years for MDD and social anxiety (anxiety-depression subscale). | Not evaluated in general population |
Price | Free | Around 2 USD per questionnaire [99] |